Entrada Therapeutics Overview
Entrada Therapeutics Discounted Cash Flow
DCF Analysis for TRDA.
Get informed when a big investor buys or sells
+ FollowFair Value
$5.99
Current Fair Value
$5.99
↓ 8.9% Downside
Overvalued by 8.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison